Assessing biosafety using NGS-based tests requires a continuum of skills in molecular biology, biocomputing, virology, and quality systems.
Audrey Brussel
Advertisement
Audrey Brussel, PhD, audrey.brussel@pathoquest.com, is Viral Safety leader at PathoQuest.
Articles by Audrey Brussel
Advertisement
Latest Updated Articles
Challenges When Outsourcing Viral Safety ServicesMay 15th 2021
Advertisement
Advertisement
Trending on BioPharm International
1
Blackstone to Provide Pfizer Up to $1.5 Billion for Monthly GLP-1 Berobenatide Development
2
The BioPharm Brief: An AI-Designed Multibody ADC Enters the Clinic, Blackstone Backs Pfizer’s Monthly GLP-1, and enGene Readies a Bladder Cancer BLA
3
enGene Plans Year-End BLA for Detalimogene in BCG-Unresponsive NMIBC
4
ImvivaBio’s Dual-Target Allogeneic CAR-T Sustains Lupus Remission Through 12 Months
5